Join Dr. Ard from the National LGBTQIA+ Health Education Center and Jeannie McIntosh from Community Health Center, Inc. for an informative webinar on the benefits and practical implementation of long-acting injectable PrEP in health centers. Focused on improving care for LGBTQIA+ communities, this webinar will explore eligibility and assessment of candidates, administering long-acting injectable PrEP, and common challenges in prescribing and integrating injectable long-acting injectable PrEP.
Learning Resources — HIV/STI Treatment and Prevention
The Intersection of HIV, Aging, and Housing: Considerations for Health Centers
This webinar from the National Center for Equitable Care for Elders (NCECE), the National Center for Health in Public Housing (NCHPH), and the National LGBTQIA+ Health Education Center will focus on integrated solutions for supporting older adults living with HIV to safely age in their community of choice.
HIV Prevention and Care for People Assigned Female at Birth
Presented by Dr. Whitney Irie and Dr. Kevin Ard in collaboration with the National LGBTQIA+ Health Education Center, this webinar will train health centers on best and promising practices for prevention and treatment of HIV among cisgender women, non-binary people assigned female at birth, and transgender men.
- Filed under
- HIV/STI Treatment and Prevention
PrEP Action Kit (2024)
This PrEP Action Kit includes clinical resources to help providers incorporate PrEP into their practices. Including helpful resources such as tips on taking a comprehensive sexual history, frequently asked questions about PrEP and information on PrEP prescribing and monitoring. This action kit is an essential resource for all providers treating LGBTQIA+ patients or patients at risk of HIV infection.
Rapid Initiation of Antiretroviral Therapy for People with HIV
Antiretroviral therapy (ART) is recommended for all people with HIV to improve and preserve their health and to reduce transmission of HIV to others. Increasingly, rapid ART starts have become a clinical and public health priority, with the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents recommending that ART be started as soon as possible after HIV diagnosis. Definitions of what constitutes a rapid start of ART vary; the most stringent is also termed immediate ART and occurs when ART is prescribed on the same day an HIV diagnosis is delivered. This fact sheet reviews the potential benefits and rationale for rapid ART starts, outlines potential pitfalls, and offers practical, evidence-based tips on ART selection for rapid starts.
- Filed under
- HIV/STI Treatment and Prevention
STI Testing and Treatment as Part of HIV Prevention
Presented by Dr. Kevin Ard, this webinar will present updated recommendations for STI testing and treatment, as well as innovations in the field such as post-exposure Doxycycline and low- threshold testing options for STIs as a part of HIV prevention and care.
- Filed under
- HIV/STI Treatment and Prevention
Innovative Methods for Delivering Pre-Exposure Prophylaxis (PrEP) Care
Presented by Dr. Kevin Ard, participants will learn about innovative approaches to HIV prevention using a status-neutral framework with information on telehealth for pre-exposure prophylaxis (PrEP), PrEP On Demand, and more. The webinar also provides the most recent information about how to implement long-acting injectable PrEP at health centers.
HIV Prevention Learning Collaborative Summary
From December 2020 through April 2023, the National LGBTQIA+ Health Education Center developed and facilitated three HIV prevention learning collaborative cohorts involving 29 organizations and 79 participants. Participants represented a range of role groups within health centers and worked in diverse locations around the country. Overall, participants described a significant amount of knowledge gained from the sessions and satisfaction with the training. Two of the cohorts overlapped with the Covid-19 pandemic; the learning collaborative’s virtual format was conducive to pandemic limitations on in-person gatherings, and the program provided a strategy to continue building capacity for PrEP during and despite the pandemic. Key lessons from the learning collaborative program include the importance of training about logistical and programmatic aspects of PrEP, the feasibility and desirability of engaging multidisciplinary teams in PrEP training, balancing education about scientific advancements in PrEP with content on implementation and addressing HIV risk perception and adherence. Going forward, we aim to create new content on risk perception and adherence and institute systematic evaluations of the learning collaborative cohorts to facilitate ongoing innovation and improvement.
Mpox: A Guide for Front-line Clinicians
Human mpox (monkeypox) is an infection characterized by rash and fever. Mpox has historically been reported in Central and Western Africa, and in early 2022, additional cases were identified in Europe and North America. By late November 2022, more than 80,000 cases had been identified in 110 countries, most of which had never previously reported the infection.
- Filed under
- HIV/STI Treatment and Prevention
What’s Next in PrEP?: New Strategies for Prevention
Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis was approved in the United States. Since then, the landscape of PrEP has shifted, with approval of additional PrEP medications and growth of low-threshold PrEP delivery strategies, such as same-day PrEP. In this interactive webinar, participants will learn about new medications in the pipeline for PrEP and emerging PrEP delivery models.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
